Wolverine Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,572
Closed -$124K 1660
2025
Q2
$137K Buy
+1,572
New +$123K ﹤0.01% 1076
2023
Q4
Sell
-2,400
Closed -$224K 1839
2023
Q3
$224K Buy
+2,400
New +$271K ﹤0.01% 1037
2020
Q3
Sell
-16
Closed -$1.67K 1592
2020
Q2
$1K Sell
16
-1,428
-99% -$128K ﹤0.01% 1489
2020
Q1
$97K Buy
+1,444
New +$89.9K ﹤0.01% 1051
2019
Q1
Sell
-53,564
Closed -$1.88M 1451
2018
Q4
$1.6M Buy
+53,564
New +$1.7M 0.02% 629
2017
Q3
Sell
-17,600
Closed -$321K 1365
2017
Q2
$321K Buy
+17,600
New +$325K ﹤0.01% 875

Other funds holding DXCM

Wolverine Asset Management's DXCM Position: Q3 2025 in Review

Wolverine Asset Management sold out of DexCom (DXCM) in Q3 2025, closing a stake of 1,572 shares — an estimated $124K sold.

Wolverine Asset Management first reported a position in DXCM in Q2 2017 and held it in 6 quarters. The position peaked at $1.6M in Q4 2018. 910 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • Wolverine Asset Management reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
  • Wolverine Asset Management sold 1,572 DexCom shares in Q3 2025, an estimated $124K.
  • Wolverine Asset Management first reported a position in DexCom in Q2 2017 and held it in 6 quarters.
  • Wolverine Asset Management's DexCom position peaked at $1.6M in Q4 2018.
  • 910 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Wolverine Asset Management's 13F filing for Q3 2025, filed 28 Oct 2025.